Head & Neck Oncology

tracked for impact factor

Open Access Editorial

Head & Neck Oncology: purpose, scope and goals-charting the future

Adel K El-Naggar1*, Colin Hopper3,4,2, Tahwinder Upile3,4,5 and Waseem Jerjes3,4,2

Author Affiliations

1 Head and Neck Pathology, Division of Pathology, UT. M.D. Anderson Cancer Center, Texas, USA

2 Head & Neck Centre, University College London Hospitals, London, UK

3 Unit of Oral & Maxillofacial Surgery, Division of Maxillofacial, Diagnostic, Medical and Surgical Sciences, UCL Eastman Dental Institute, London, UK

4 Department of Surgery, University College London Medical School, London, UK

5 Department of Head & Neck Surgery, the Professorial Unit, the Royal National Throat, Nose and Ear Hospital, London, UK

For all author emails, please log on.

Head & Neck Oncology 2009, 1:1 doi:10.1186/1758-3284-1-1

Published: 12 January 2009

Abstract

For many years now there has been a growing frustration with the statistics of head and neck cancer. Despite the many advances in diagnosis and therapy, there has been little change in the prognosis for most cancers of the head and neck in the last 50 years, so what is the point of yet another journal? Well, it is not all bad news.